Followers | 377 |
Posts | 17270 |
Boards Moderated | 3 |
Alias Born | 03/07/2014 |
Thursday, September 04, 2014 12:25:41 AM
1) It says a final trial for them (Meso) of 120 patients.
"Final phase trials on 120 heart disease sufferers follow a successful earlier trial on 30 patients which showed that the therapy worked safely on a small number of patients.
"
2) The article is FULL of "maybe" and "if" and "might prove" and "could result" and "perhaps will be", etc. In other words- NOTHING of this is stem cell tech is even remotely close to proven "science" or reality or a even remotely close to a salable, safe product yet IMO, and apparently that of the experts they site in the article.
3) How long to "possibly" be a product? Well, what does the article say verbatim:
"Experts said that if the larger trial proves to be an equal success then the first stem cell-based therapy to treat advanced heart failure – known scientifically as “class IV” failure – could be on the market in six years."
SIX YEARS "if" all goes well and it proves out to be good science. And that is directly in line with other world, actual "experts" such as the 60 minutes piece- in which some of the world leaders from Duke and Stanford, etc said they estimated NINE yrs at least to a viable "stem cell" treatment for several of the maladies discussed, including heart related.
THAT is what the article cited says, using direct quotes. NOWHERE is 1700 patients mentioned, and very little details are given other than vague terms like it "might prove a success", but the only speculative date given is SIX YEARS FROM NOW- to a "possible" product.
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM